Noriyuki Kasahara
Technik-/Wissenschafts-/F&E-Leiter bei 4D MOLECULAR THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Noriyuki Kasahara
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
The University of California, San Francisco
23
| College/University | Other Consumer Services | 23 |
| Public Company | Biotechnology | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Noriyuki Kasahara
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Founder Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal President | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
| University of Illinois | College/University | Doctorate Degree Doctorate Degree | |
| JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| IGNYTA INC | Biotechnology | Director of Finance/CFO | |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
| RENTPATH INC | Internet Software/Services | Director/Board Member | |
| Stony Brook University | College/University | Undergraduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
Envision Pharmaceutical Services LLC
 Envision Pharmaceutical Services LLC Insurance Brokers/ServicesFinance Envision Pharmaceutical Services LLC provides pharmacy benefits management services. Its services include pharmacy benefit management, pharmacies, savings programs, insurance and clinical care and member engagement. The company was founded by James Mindala, Kevin M. Nagle and Barry Katz in 2001 and is headquartered in Twinsburg, OH. | Insurance Brokers/Services | Director/Board Member | |
TPG Capital LP
 TPG Capital LP Financial ConglomeratesFinance TPG Capital LP provides financial investment services. The company was founded by David Bonderman, William S. Price III and James George Coulter Jr. and is headquartered in Houston, TX. | Financial Conglomerates | Corporate Officer/Principal | |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Pharmaceuticals: Major | Director/Board Member | |
| Macula Society | Corporate Officer/Principal | ||
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The University of Southampton | College/University | Undergraduate Degree | |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Envision Rx Options Holdings, Inc. | Director/Board Member | ||
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Chairman | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
Packard Children's Health Alliance
 Packard Children's Health Alliance Hospital/Nursing ManagementHealth Services Packard Children's Health Alliance operates a medical and surgical hospital for children. The private company is based in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 4 |
| Schweiz | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 17 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 136 |
| Corporate Officer/Principal | 102 |
| Independent Dir/Board Member | 49 |
| Chief Tech/Sci/R&D Officer | 46 |
| Undergraduate Degree | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Louis C. Bock | 27 |
| Marc Tessier-Lavigne | 24 |
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Mark Smith | 20 |
| Jacob Chacko | 18 |
| Nancy Miller-Rich | 15 |
| Michael C. Venuti | 15 |
| Julie Hambleton | 15 |
| Barbara Finck | 15 |
| David Kirn | 13 |
| Joseph Martin | 13 |
| Robert Fishman | 11 |
| August Moretti | 10 |
| Sara White | 10 |
- Börse
- Insiders
- Noriyuki Kasahara
- Unternehmensverbindungen
